|
 Quest Diagnostics <DGX.N> on Saturday received the first emergency
authorization from the U.S. Food and Drug Administration to use
pooled testing to help reduce its backlog of COVID-19 tests. The
following is a description of how it works and the advantages and
disadvantages of pooled testing.
How does pooled testing work?
In pooled testing, laboratories combine samples taken from several
people and test the multiple specimens together for the presence of
genetic material from the novel coronavirus. If a batch tests
negative for COVID-19, all those patients are cleared. If a batch
tests positive, the specimens must be retested individually or in
smaller groups.
Such tests could be used to quickly clear groups of people who are
not likely carriers, such as students returning to school, or
individuals in areas with relatively low active COVID-19 infection
levels.
"This type of testing works really well when you have an
asymptomatic patient population or you're doing some contact tracing
where the likelihood of the prevalence of someone having the
SARS-CoV virus is rather low, because you could test multiple groups
and get tons of negatives," said Carmen Wiley, president of the
American Association for Clinical Chemistry (AACC).
[to top of second column] |
What are the benefits of pooled testing?
U.S. independent labs and hospitals are struggling to meet surging demand for
tests as infection rates climb in many parts of the country. Waits of more than
a week for results, which has become common, defeats the purpose of trying slow
the virus' spread by identifying who may be contagious before they can infect
others. Pooled testing could alleviate some of that problem.
If a laboratory were to test a batch of 12 specimens, one of which was positive,
it could then test smaller batches of four samples each. The smaller group with
the positive sample would then be tested individually to identify the infected
person. That process requiring seven tests is still a 42% reduction versus 12
individual tests.
Fewer tests not only means quicker results, but frees up testing materials that
have been in short supply, like chemical reagents.
What are the drawbacks?
If the disease is prevalent in a community - more than around 10 percent,
according to the AACC - pooled testing stops being useful because so many
follow-up tests are likely to be required.
Pooled tests may also result in an increase in false negatives because combined
samples are diluted, making it more difficult to pick up the virus material,
according to the FDA. Quest, however, says that in clinical data it presented to
regulators for its method of pooled testing, it would not have found a false
negative in more than 3,000 total specimens.
(Reporting by Michael Erman; editing by Peter Henderson and Bill Berkrot)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |
